Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Oral Poster

YIM Oral

Poster

1201 - IFNγ/IL21-JAK-STAT1 Signaling Axis Drives T-Cell–Mediated CLL Proliferation and Venetoclax Resistance

    Primary Author / Presenter(s)

  • MB

    Miroslav Boudny, PhD

    Postdoc
    Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

    • Co-Author(s)

  • EB

    Erika Bajusova, BS

    Master’s student
    CEITEC, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • Pedro Faria Zeni, MSc

    PhD student
    Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • DF

    Daniel Filip, MSc

    PhD student
    Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • EH

    Eva Hoferkova, PhD

    Postdoc
    Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • LO

    Laura Ondrisova, MSc

    PhD student
    Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • JV

    Josef Vecera, PhD

    Postdoc
    Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • KM

    Kvetoslava Matulova, PhD

    Assistant professor
    Dept of Pathology, University Hospital Brno and Faculty of Medicine, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • ÅP

    Šárka Pospíšilová, PhD

    Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic; Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Central European Institute of Technology, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • Vaclav Seda, PhD

    Postdoc
    Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • PP

    Petra Pavelkova, MSc

    PhD student
    Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • KH

    Krystof Hlavac, MSc

    PhD student
    Dept of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Rep.; CEITEC, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • NB

    Nicolas Blavet, PhD

    Senior researcher
    Bioinformatics Core Facility, CEITEC, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • LK

    Leos Kren, MD, PhD

    Associate professor
    Department of Pathology, University Hospital Brno and Faculty of Medicine, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • AP

    Anna Panovská, MD, PhD

    Assistant professor
    Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University
    Brno, Jihomoravsky kraj, Czech Republic

  • Michael Doubek, MD, PhD

    Department head
    Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic; Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Central European Institute of Technology, Masaryk University, Brno, Czech Republic
    Brno, Jihomoravsky kraj, Czech Republic

  • Marek Mraz, MD, PhD

    PI
    CEITEC Masaryk University and University Hospital Brno
    Brno, Czech Republic